secwatch.observer — SEC 8-K summary
======================================

Issuer:     InnovAge Holding Corp. (INNV)
CIK:        0001834376
Form:       8-K
Filed at:   2023-03-01T23:59:59+00:00
Accession:  0001104659-23-027377
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InnovAge appoints Christine Bent as COO effective March 20, 2023; Maria Lozzano transitions to Senior Advisor
--------------------------------------------------------------------------------

- Christine Bent appointed COO effective March 20, 2023; replaces Maria Lozzano who becomes Senior Advisor to CEO and COO through August 4, 2023.
- Bent's employment agreement includes $455,000 base salary, 50% target bonus, $400,000 annual RSU grant, and initial $575,000 RSU grant vesting over 3 years.
- Lozzano will receive base salary continuation for 12 months post-separation, pro-rata bonus, and healthcare coverage under transition agreement.
- Bent previously SVP and COO at Prime Therapeutics; also held leadership roles at Allina Health and Atrius Health.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1834376/000110465923027377/0001104659-23-027377-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1834376/000110465923027377/tm238090d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-027377

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer